시장보고서

상품코드

1606391

동물용 종양학 시장 : 치료 유형별, 동물 유형별, 암 유형별, 제품 유형별, 최종사용자별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

Veterinary Oncology Market, By Therapy Type, By Animal Type, By Cancer Type, By Product Type, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

발행일: 2024년 11월 | 리서치사:

AnalystView Market Insights | 페이지 정보: 영문 301 Pages | 배송안내 : 2-3일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

동물용 종양학 시장 규모는 2023년 11억 832만 달러로 2024년부터 2032년까지 연평균 11.30%의 CAGR로 확대될 것으로 예상됩니다.

동물용 종양학 시장 - 시장 역학

반려동물 사육 및 지출 증가로 동물용 종양학 시장의 수요 증가

반려동물 사육 증가 추세와 반려동물 건강관리에 대한 지출 증가는 동물용 종양학 시장의 괄목할만한 성장을 촉진하고 있습니다. 반려동물을 가족의 일원으로 인식하게 되면서 반려동물 보호자들은 반려동물의 건강을 지키기 위해 암 치료를 포함한 첨단 의료에 더 기꺼이 투자하고 있습니다. 이러한 인식의 변화는 가처분 소득의 증가에 힘입어 동물용 종양학 서비스에 대한 수요 증가로 이어지고 있습니다. 또한, 반려동물 암에 대한 인식의 증가와 전문 치료법의 가용성은 시장 확대에 더욱 기여하고 있으며, 이 분야의 지속적인 발전의 중요한 필요성을 강조하고 있습니다.

동물용 종양학 시장 - 주요 인사이트

당사의 리서치 애널리스트가 공유한 분석에 따르면, 세계 시장은 예측 기간(2024-2032년) 동안 매년 약 11.30%의 CAGR로 성장할 것으로 예상됩니다.

동물 유형별로는 축산 동물이 2023년 가장 큰 시장 점유율을 보일 것으로 예측됩니다.

치료 유형별로는 화학요법이 2023년 주요 치료 유형으로 나타났습니다.

최종사용자별로는 동물병원이 2023년 주요 유형으로 나타났습니다.

지역별로는 아시아태평양이 2023년 매출 1위를 차지했습니다.

동물용 종양학 시장 - 세분화 분석:

세계 동물용 종양학 시장은 치료 유형, 동물 유형, 암 유형, 동물 유형, 최종사용자 및 지역을 기준으로 세분화됩니다.

동물 유형에 따라 시장은 반려동물과 축산 동물의 두 가지 범주로 나뉩니다. 동물 복지의 중요성에 대한 인식이 높아지고 있으며, 이는 암을 포함한 질병 관리에도 영향을 미치고 있습니다. 농부들과 가축 소유주들은 동물의 건강 관리를 개선하기 위해 투자하고 있으며, 이는 종양학 서비스에 대한 수요를 촉진하고 있습니다. 소, 닭, 돼지와 같은 가축은 세계 경제에 필수적이며, 육류, 유제품, 계란과 같은 식품을 제공합니다. 암 치료를 포함한 가축의 건강을 보장하는 것은 경제적 손실을 막는 데 매우 중요합니다.

시장은 최종사용자에 따라 동물병원, 동물병원, 동물진료소, 연구기관, 학술기관의 네 가지 범주로 나뉩니다. 동물용 종양학 시장에서 동물병원의 시장 점유율이 높은 것은 몇 가지 요인에 기인합니다. 동물병원은 다양한 동물의 일차 진료 센터로서 화학요법, 방사선 요법, 수술 등 전문적인 암 치료를 제공하고 있습니다. 이러한 시설은 종종 고급 진단 도구, 특수 장비, 숙련된 수의 종양 전문의가 있어 암에 걸린 반려동물의 치료의 질을 향상시킵니다.

동물용 종양학 시장 - 지리적 인사이트

아시아태평양의 동물용 종양학 시장은 반려동물 인구 증가, 동물 건강에 대한 인식 증가, 수의학 진단 및 치료의 발전으로 인해 괄목할 만한 성장세를 보이고 있습니다. 중국, 일본, 인도와 같은 국가들은 반려동물 인구의 증가와 첨단 수의학 진료의 채택으로 시장 확대에 크게 기여하고 있습니다. 일본은 특히 정교한 동물 의료 인프라로 유명하며, 중국과 인도는 반려동물용 종양학 서비스에 대한 수요가 빠르게 증가하고 있습니다. 동물의 암 유병률 증가는 수의학 전문 클리닉의 발전과 치료 옵션의 확대와 함께 이 지역의 시장을 더욱 촉진하고 있습니다.

동물용 종양학 시장 - 경쟁 환경:

동물용 종양 시장의 경쟁 구도는 동물용 암 진단, 치료제, 첨단 치료 솔루션을 제공하는 주요 업체들이 주도하고 있으며, Zoetis Inc. 연구 역량과 제품 포트폴리오를 활용하여 반려동물의 다양한 암에 대응하고 있습니다. 이들 시장 리더들은 표적 치료제, 면역치료제 등 혁신적인 치료법에 집중하고 있습니다. 또한, VetDC와 AB Science와 같은 중소기업과 전문 기업들도 새로운 화학요법이나 키나아제 억제제와 같은 틈새 제품에서 주도적인 역할을 하고 있습니다. 공동 연구, 전략적 인수 및 제휴는 일반적으로 기업들이 기술 역량을 확장하고 사업 범위를 넓힐 수 있도록 도와줍니다. 보다 효과적이고 안전한 치료법에 대한 수요 증가와 반려동물 사육 및 수의학에 대한 수요 증가는 이 시장의 경쟁을 계속 촉진하고 있습니다.

소개
북미
- 개요
- 북미의 주요 제조업체
- 미국
- 캐나다
유럽
- 개요
- 유럽의 주요 제조업체
- 독일
- 이탈리아
- 영국
- 프랑스
- 러시아
- 네덜란드
- 스웨덴
- 폴란드
- 기타
아시아태평양
- 개요
- 아시아태평양의 주요 제조업체
- 인도
- 중국
- 일본
- 한국
- 호주
- 태국
- 인도네시아
- 필리핀
- 기타
라틴아메리카
- 개요
- 라틴아메리카의 주요 제조업체
- 브라질
- 멕시코
- 아르헨티나
- 콜롬비아
- 기타
중동 및 아프리카
- 개요
- 중동 및 아프리카의 주요 제조업체
- 사우디아라비아
- 아랍에미리트
- 이스라엘
- 터키
- 알제리
- 이집트
- 기타

제13장 주요 벤더 분석 - 동물용 종양학 업계

경쟁 대시보드
기업 개요
- Zoetis Inc.
- Boehringer Ingelheim Animal Health
- Elanco Animal Health
- Merck Animal Health(a division of Merck &Co., Inc.)
- AB Science
- Aratana Therapeutics
- Regeneus Ltd
- Varian Medical Systems
- VetDC
- Karyopharm Therapeutics
- Others

제14장 애널리스트의 전방위 전망

ksm 24.12.19

REPORT HIGHLIGHT

Veterinary Oncology Market size was valued at USD 1,108.32 million in 2023, expanding at a CAGR of 11.30% from 2024 to 2032.

The veterinary oncology market focuses on the diagnosis and treatment of cancer in animals, primarily companion animals like dogs and cats. It includes various services and products such as chemotherapy, immunotherapy, radiation therapy, and surgery. The rising pet ownership, growing awareness of animal health, and advancements in veterinary care have driven the market's growth. Additionally, the increasing incidence of cancer in pets and the availability of advanced diagnostic tools contribute to market expansion. The sector is supported by veterinary pharmaceutical companies and specialized clinics, with innovations in targeted therapies and personalized treatments enhancing the market's potential.

Veterinary Oncology Market- Market Dynamics

Increasing Pet Ownership and Spending Drives the Need for the Veterinary Oncology Market

The rising trend of pet ownership and increased spending on pet healthcare is driving significant growth in the veterinary oncology market. As pets are increasingly considered part of the family, pet owners are more willing to invest in advanced medical treatments, including cancer therapies, to ensure their pets' well-being. This shift in attitude, supported by higher disposable incomes, has resulted in greater demand for veterinary oncology services. Additionally, the growing awareness of pet cancers and the availability of specialized treatments have further contributed to market expansion, highlighting the crucial need for continued advancements in this field.

Veterinary Oncology Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 11.30% over the forecast period (2024-2032)

Based on animal type segmentation, Livestock Animals was predicted to show maximum market share in the year 2023

Based on therapy type segmentation, Chemotherapy was the leading type in 2023

Based on end-user segmentation, Veterinary Hospitals was the leading type in 2023

Based on region, Asia Pacific was the leading revenue generator in 2023

Veterinary Oncology Market- Segmentation Analysis:

The Global Veterinary Oncology Market is segmented based on Therapy Type, Animal Type, Cancer Type, Animal Type, End User, and Region.

The market is divided into two categories based on animal type: Companion Animals, and Livestock Animals. There is increasing awareness about the importance of animal welfare, which extends to disease management, including cancer. Farmers and livestock owners are investing in better healthcare for their animals, driving demand for oncology services. Livestock animals, such as cattle, poultry, and swine, are vital to the global economy, providing food products like meat, dairy, and eggs. Ensuring their health, including cancer treatment, is critical to preventing economic losses.

The market is divided into four categories based on end users: Veterinary Hospitals, Veterinary Clinics, Research Institutes, and Academic Institutions. The high market share of veterinary hospitals in the veterinary oncology market can be attributed to several factors. Veterinary hospitals serve as primary care centers for a wide range of animals, offering specialized cancer treatments such as chemotherapy, radiation therapy, and surgery. These facilities often have access to advanced diagnostic tools, specialized equipment, and skilled veterinary oncologists, which enhances the quality of care for pets with cancer.

Veterinary Oncology Market- Geographical Insights

The veterinary oncology market in the Asia Pacific region is experiencing notable growth, driven by rising pet ownership, increasing awareness about animal health, and advancements in veterinary diagnostics and treatments. Countries like China, Japan, and India are key contributors to market expansion due to their growing pet populations and the adoption of advanced veterinary practices. Japan is particularly known for its sophisticated veterinary healthcare infrastructure, while China and India are witnessing rapid growth in demand for oncology services for pets. The increasing prevalence of cancer in animals, combined with the development of veterinary specialty clinics and an expanding range of treatment options, further propels the market in this region.

Veterinary Oncology Market- Competitive Landscape:

The competitive landscape of the veterinary oncology market is marked by key players offering a range of diagnostics, therapeutics, and advanced treatment solutions for animal cancers. Companies like Zoetis Inc., Elanco Animal Health, and Merck Animal Health are at the forefront, leveraging their extensive research capabilities and product portfolios to address various forms of cancer in pets. These market leaders focus on innovative therapies such as targeted treatments and immunotherapies. In addition, smaller companies and specialized firms, such as VetDC and AB Science, are also gaining traction with niche products like novel chemotherapies and kinase inhibitors. Collaborations, strategic acquisitions, and partnerships are common, allowing players to expand their technological capabilities and reach. The growing demand for more effective and safer treatments and increased pet ownership and veterinary care continue to drive competition in this market.

Recent Developments:

In August 2024, Akston Biosciences Corporation, which is dedicated to accelerating the biologics revolution in Animal Health, and Purdue University announced a strategic partnership to co-develop an anti-cPD-L1 monoclonal antibody (mAb) immunotherapy to treat cancer in dogs.

In September 2024, CureLab Veterinary Inc, a biopharmaceutical company that develops cancer treatments for pets, announced a Regulation D fundraising offer to develop its gene therapy, ElenaVet, which enhances the body's anticancer immune response and reduces chronic inflammation. The offering is being carried out in compliance with Rule 506(c) of Regulation D, which was issued under the amended Securities Act of 1933.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL VETERINARY ONCOLOGY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Zoetis Inc.
Boehringer Ingelheim Animal Health
Elanco Animal Health
Merck Animal Health (a division of Merck & Co., Inc.)
AB Science
Aratana Therapeutics
Regeneus Ltd
Varian Medical Systems
VetDC
Karyopharm Therapeutics
Others

GLOBAL VETERINARY ONCOLOGY MARKET, BY THERAPY TYPE- MARKET ANALYSIS, 2019 - 2032

Chemotherapy
Radiation Therapy
Immunotherapy
Surgery
Targeted Therapy
Combination Therapy

GLOBAL VETERINARY ONCOLOGY MARKET, BY ANIMAL TYPE - MARKET ANALYSIS, 2019 - 2032

Companion Animals
Dogs
Cats
Livestock Animals
Horses
Cattle
Others

GLOBAL VETERINARY ONCOLOGY MARKET, BY CANCER TYPE- MARKET ANALYSIS, 2019 - 2032

Lymphoma
Mast Cell Cancer
Mammary and Breast Cancer
Melanoma
Bone Cancer (Osteosarcoma)
Hemangiosarcoma
Other Tumors (e.g., Skin, Oral, etc.)

GLOBAL VETERINARY ONCOLOGY MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

Drugs
Chemotherapeutic Agents
Targeted Drugs
Immunotherapy Agents
Devices
Radiation Therapy Equipment
Imaging Devices (MRI, CT Scanners, etc.)
Surgical Instruments

GLOBAL VETERINARY ONCOLOGY MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

Veterinary Hospitals
Veterinary Clinics
Research Institutes
Academic Institutions

GLOBAL VETERINARY ONCOLOGY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Veterinary Oncology Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Veterinary Oncology Market Snippet by Therapy Type
- 2.1.2. Veterinary Oncology Market Snippet by Animal Type
- 2.1.3. Veterinary Oncology Market Snippet by Cancer Type
- 2.1.4. Veterinary Oncology Market Snippet by Product Type
- 2.1.5. Veterinary Oncology Market Snippet by End User
- 2.1.6. Veterinary Oncology Market Snippet by Country
- 2.1.7. Veterinary Oncology Market Snippet by Region
2.2. Competitive Insights

3. Veterinary Oncology Key Market Trends

3.1. Veterinary Oncology Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Veterinary Oncology Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Veterinary Oncology Market Opportunities
3.4. Veterinary Oncology Market Future Trends

4. Veterinary Oncology Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Veterinary Oncology Market: COVID-19 Impact Analysis

5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments

6. Veterinary Oncology Market Landscape

6.1. Veterinary Oncology Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Veterinary Oncology Market - By Therapy Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Therapy Type, 2023 & 2032 (%)
- 7.1.2. Chemotherapy
- 7.1.3. Radiation Therapy
- 7.1.4. Immunotherapy
- 7.1.5. Surgery
- 7.1.6. Targeted Therapy
- 7.1.7. Combination Therapy

8. Veterinary Oncology Market - By Animal Type

8.1. Overview
- 8.1.1. Segment Share Analysis, By Animal Type, 2023 & 2032 (%)
- 8.1.2. Companion Animals
  - 8.1.2.1. Dogs
  - 8.1.2.2. Cats
- 8.1.3. Livestock Animals
  - 8.1.3.1. Horses
  - 8.1.3.2. Cattle
  - 8.1.3.3. Others

9. Veterinary Oncology Market - By Cancer Type

9.1. Overview
- 9.1.1. Segment Share Analysis, By Cancer Type, 2023 & 2032 (%)
- 9.1.2. Lymphoma
- 9.1.3. Mast Cell Cancer
- 9.1.4. Mammary and Breast Cancer
- 9.1.5. Melanoma
- 9.1.6. Bone Cancer (Osteosarcoma)
- 9.1.7. Hemangiosarcoma
- 9.1.8. Other Tumors (e.g., Skin, Oral, etc.)

10. Veterinary Oncology Market - By Product Type

10.1. Overview
- 10.1.1. Segment Share Analysis, By Animal Type, 2023 & 2032 (%)
- 10.1.2. Drugs
  - 10.1.2.1. Chemotherapeutic Agents
  - 10.1.2.2. Targeted Drugs
  - 10.1.2.3. Immunotherapy Agents
- 10.1.3. Devices
  - 10.1.3.1. Radiation Therapy Equipment
  - 10.1.3.2. Imaging Devices (MRI, CT Scanners, etc.)
  - 10.1.3.3. Surgical Instruments

11. Veterinary Oncology Market - By End User

11.1. Overview
- 11.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
- 11.1.2. Veterinary Hospitals
- 11.1.3. Veterinary Clinics
- 11.1.4. Research Institutes
- 11.1.5. Academic Institutions

12. Veterinary Oncology Market- By Geography

12.1. Introduction
- 12.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
12.2. North America
- 12.2.1. Overview
- 12.2.2. Veterinary Oncology Key Manufacturers in North America
- 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.2.4. North America Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
- 12.2.5. North America Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
- 12.2.6. North America Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
- 12.2.7. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 12.2.8. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.2.9. U.S.
  - 12.2.9.1. Overview
  - 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.2.9.3. U.S. Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 12.2.9.4. U.S. Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
  - 12.2.9.5. U.S. Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
  - 12.2.9.6. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.2.9.7. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.2.10. Canada
  - 12.2.10.1. Overview
  - 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.2.10.3. Canada Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 12.2.10.4. Canada Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
  - 12.2.10.5. Canada Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
  - 12.2.10.6. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.2.10.7. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3. Europe
- 12.3.1. Overview
- 12.3.2. Veterinary Oncology Key Manufacturers in Europe
- 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.3.4. Europe Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
- 12.3.5. Europe Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
- 12.3.6. Europe Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
- 12.3.7. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 12.3.8. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.9. Germany
  - 12.3.9.1. Overview
  - 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.9.3. Germany Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 12.3.9.4. Germany Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
  - 12.3.9.5. Germany Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
  - 12.3.9.6. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.9.7. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.10. Italy
  - 12.3.10.1. Overview
  - 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.10.3. Italy Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 12.3.10.4. Italy Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
  - 12.3.10.5. Italy Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
  - 12.3.10.6. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.10.7. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.11. United Kingdom
  - 12.3.11.1. Overview
  - 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.11.3. United Kingdom Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 12.3.11.4. United Kingdom Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
  - 12.3.11.5. United Kingdom Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
  - 12.3.11.6. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.11.7. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.12. France
  - 12.3.12.1. Overview
  - 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.12.3. France Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 12.3.12.4. France Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
  - 12.3.12.5. France Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
  - 12.3.12.6. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.12.7. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.13. Russia
  - 12.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.13.2. Russia Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 12.3.13.3. Russia Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
  - 12.3.13.4. Russia Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
  - 12.3.13.5. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.13.6. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.14. Netherlands
  - 12.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.14.2. Netherlands Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 12.3.14.3. Netherlands Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
  - 12.3.14.4. Netherlands Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
  - 12.3.14.5. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.14.6. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.15. Sweden
  - 12.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.15.2. Sweden Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 12.3.15.3. Sweden Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
  - 12.3.15.4. Sweden Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
  - 12.3.15.5. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.15.6. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.16. Poland
  - 12.3.16.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.16.2. Poland Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 12.3.16.3. Poland Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
  - 12.3.16.4. Poland Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
  - 12.3.16.5. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.16.6. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.17. Rest of Europe
  - 12.3.17.1. Overview
  - 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.17.3. Rest of the Europe Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 12.3.17.4. Rest of the Europe Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
  - 12.3.17.5. Rest of the Europe Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
  - 12.3.17.6. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.17.7. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4. Asia Pacific (APAC)
- 12.4.1. Overview
- 12.4.2. Veterinary Oncology Key Manufacturers in Asia Pacific
- 12.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.4.4. Asia Pacific Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
- 12.4.5. Asia Pacific Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
- 12.4.6. Asia Pacific Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
- 12.4.7. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 12.4.8. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.9. India
  - 12.4.9.1. Overview
  - 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.9.3. India Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 12.4.9.4. India Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
  - 12.4.9.5. India Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
  - 12.4.9.6. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.4.9.7. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.10. China
  - 12.4.10.1. Overview
  - 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.10.3. China Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 12.4.10.4. China Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
  - 12.4.10.5. China Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
  - 12.4.10.6. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.4.10.7. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.11. Japan
  - 12.4.11.1. Overview
  - 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.11.3. Japan Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 12.4.11.4. Japan Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
  - 12.4.11.5. Japan Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
  - 12.4.11.6. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.4.11.7. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.12. South Korea
  - 12.4.12.1. Overview
  - 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.12.3. South Korea Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 12.4.12.4. South Korea Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
  - 12.4.12.5. South Korea Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
  - 12.4.12.6. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.4.12.7. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.13. Australia
  - 12.4.13.1. Overview
  - 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.13.3. Australia Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 12.4.13.4. Australia Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
  - 12.4.13.5. Australia Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
  - 12.4.13.6. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.4.13.7. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.14. Thailand
  - 12.4.14.1. Overview
  - 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.14.3. Thailand Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 12.4.14.4. Thailand Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
  - 12.4.14.5. Thailand Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
  - 12.4.14.6. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.4.14.7. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.15. Indonesia
  - 12.4.15.1. Overview
  - 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.15.3. Indonesia Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 12.4.15.4. Indonesia Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
  - 12.4.15.5. Indonesia Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
  - 12.4.15.6. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.4.15.7. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.16. Philippines
  - 12.4.16.1. Overview
  - 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.16.3. Philippines Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 12.4.16.4. Philippines Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
  - 12.4.16.5. Philippines Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
  - 12.4.16.6. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.4.16.7. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.17. Rest of APAC
  - 12.4.17.1. Overview
  - 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.17.3. Rest of APAC Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 12.4.17.4. Rest of APAC Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
  - 12.4.17.5. Rest of APAC Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
  - 12.4.17.6. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5. Latin America
- 12.5.1. Overview
- 12.5.2. Veterinary Oncology Key Manufacturers in Latin America
- 12.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.5.4. Latin America Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
- 12.5.5. Latin America Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
- 12.5.6. Latin America Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
- 12.5.7. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 12.5.8. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.5.9. Brazil
  - 12.5.9.1. Overview
  - 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.9.3. Brazil Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 12.5.9.4. Brazil Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
  - 12.5.9.5. Brazil Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
  - 12.5.9.6. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.5.9.7. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.5.10. Mexico
  - 12.5.10.1. Overview
  - 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.10.3. Mexico Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 12.5.10.4. Mexico Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
  - 12.5.10.5. Mexico Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
  - 12.5.10.6. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.5.10.7. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.5.11. Argentina
  - 12.5.11.1. Overview
  - 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.11.3. Argentina Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 12.5.11.4. Argentina Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
  - 12.5.11.5. Argentina Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
  - 12.5.11.6. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.5.11.7. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.5.12. Colombia
  - 12.5.12.1. Overview
  - 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.12.3. Colombia Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 12.5.12.4. Colombia Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
  - 12.5.12.5. Colombia Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
  - 12.5.12.6. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.5.12.7. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.5.13. Rest of LATAM
  - 12.5.13.1. Overview
  - 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.13.3. Rest of LATAM Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 12.5.13.4. Rest of LATAM Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
  - 12.5.13.5. Rest of LATAM Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
  - 12.5.13.6. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6. Middle East and Africa
- 12.6.1. Overview
- 12.6.2. Veterinary Oncology Key Manufacturers in Middle East and Africa
- 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.6.4. Middle East and Africa Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
- 12.6.5. Middle East and Africa Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
- 12.6.6. Middle East and Africa Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
- 12.6.7. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.9. Saudi Arabia
  - 12.6.9.1. Overview
  - 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.9.3. Saudi Arabia Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 12.6.9.4. Saudi Arabia Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
  - 12.6.9.5. Saudi Arabia Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
  - 12.6.9.6. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.10. United Arab Emirates
  - 12.6.10.1. Overview
  - 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.10.3. United Arab Emirates Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 12.6.10.4. United Arab Emirates Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
  - 12.6.10.5. United Arab Emirates Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
  - 12.6.10.6. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.11. Israel
  - 12.6.11.1. Overview
  - 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.11.3. Israel Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 12.6.11.4. Israel Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
  - 12.6.11.5. Israel Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
  - 12.6.11.6. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.6.11.7. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.12. Turkey
  - 12.6.12.1. Overview
  - 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.12.3. Turkey Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 12.6.12.4. Turkey Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
  - 12.6.12.5. Turkey Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
  - 12.6.12.6. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.6.12.7. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.13. Algeria
  - 12.6.13.1. Overview
  - 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.13.3. Algeria Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 12.6.13.4. Algeria Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
  - 12.6.13.5. Algeria Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
  - 12.6.13.6. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.6.13.7. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.14. Egypt
  - 12.6.14.1. Overview
  - 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.14.3. Egypt Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 12.6.14.4. Egypt Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
  - 12.6.14.5. Egypt Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
  - 12.6.14.6. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.6.14.7. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.15. Rest of MEA
  - 12.6.15.1. Overview
  - 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.15.3. Rest of MEA Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 12.6.15.4. Rest of MEA Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
  - 12.6.15.5. Rest of MEA Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
  - 12.6.15.6. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

13. Key Vendor Analysis- Veterinary Oncology Industry

13.1. Competitive Dashboard
13.2. Company Profiles
- 13.2.1. Zoetis Inc.
- 13.2.2. Boehringer Ingelheim Animal Health
- 13.2.3. Elanco Animal Health
- 13.2.4. Merck Animal Health (a division of Merck & Co., Inc.)
- 13.2.5. AB Science
- 13.2.6. Aratana Therapeutics
- 13.2.7. Regeneus Ltd
- 13.2.8. Varian Medical Systems
- 13.2.9. VetDC
- 13.2.10. Karyopharm Therapeutics
- 13.2.11. Others

14. 360 Degree Analyst View

15. Appendix

15.1. Research Methodology
15.2. References
15.3. Abbreviations
15.4. Disclaimer
15.5. Contact Us